Camurus AB Financials
| CAMX Stock | SEK 573.00 12.00 2.14% |
Camurus |
Understanding current and past Camurus AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Camurus AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Camurus AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Camurus AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Camurus AB. Check Camurus AB's Beneish M Score to see the likelihood of Camurus AB's management manipulating its earnings.
Camurus AB Stock Summary
Camurus AB competes with BioArctic, Oncopeptides, Hansa Biopharma, and Swedish Orphan. Camurus AB , a pharmaceutical company, develops and commercializes pharmaceuticals for serious and chronic conditions in Europe, Australia, the United States, Japan, and internationally. The company was founded in 1991 and is headquartered in Lund, Sweden. Camurus AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 140 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0007692850 |
| Business Address | Ideon Science Park, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.camurus.com |
| Phone | 46 4 62 86 57 30 |
| Currency | SEK - Swedish Kronor |
You should never invest in Camurus AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Camurus Stock, because this is throwing your money away. Analyzing the key information contained in Camurus AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Camurus AB Key Financial Ratios
Camurus AB's financial ratios allow both analysts and investors to convert raw data from Camurus AB's financial statements into concise, actionable information that can be used to evaluate the performance of Camurus AB over time and compare it to other companies across industries.| Return On Equity | 0.0317 | |||
| Return On Asset | 0.0146 | |||
| Target Price | 298.0 | |||
| Number Of Employees | 170 | |||
| Beta | 0.99 |
Camurus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Camurus AB's current stock value. Our valuation model uses many indicators to compare Camurus AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Camurus AB competition to find correlations between indicators driving Camurus AB's intrinsic value. More Info.Camurus AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Camurus AB is roughly 2.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Camurus AB's earnings, one of the primary drivers of an investment's value.Camurus AB Systematic Risk
Camurus AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Camurus AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Camurus AB correlated with the market. If Beta is less than 0 Camurus AB generally moves in the opposite direction as compared to the market. If Camurus AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Camurus AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Camurus AB is generally in the same direction as the market. If Beta > 1 Camurus AB moves generally in the same direction as, but more than the movement of the benchmark.
Camurus AB November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Camurus AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Camurus AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Camurus AB based on widely used predictive technical indicators. In general, we focus on analyzing Camurus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Camurus AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 16.63 | |||
| Value At Risk | (6.32) | |||
| Potential Upside | 2.41 |
Additional Tools for Camurus Stock Analysis
When running Camurus AB's price analysis, check to measure Camurus AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Camurus AB is operating at the current time. Most of Camurus AB's value examination focuses on studying past and present price action to predict the probability of Camurus AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Camurus AB's price. Additionally, you may evaluate how the addition of Camurus AB to your portfolios can decrease your overall portfolio volatility.